top of page

Tamoxifen Side Effects: Everything You Need to Know Before Starting the Medication

  • ป้าหมอนุช
  • May 15
  • 8 min read

Tamoxifen is a selective estrogen receptor modulator (SERM) used as a standard treatment for hormone-receptor-positive (HR+) breast cancer for 5-10 years, and also for breast cancer prevention in high-risk women. Common side effects include hot flashes, night sweats, vaginal discharge, irregular menstruation, and mood swings. Side effects requiring special monitoring include deep vein thrombosis (DVT/PE) and endometrial cancer in postmenopausal women. Close monitoring and awareness of warning signs are key to safe use of this medication.

What is Tamoxifen?

Tamoxifen is a selective estrogen receptor modulator (SERM) that works by binding to estrogen receptors in breast cancer cells—blocking the binding of estrogen and preventing the growth of cancer cells.

How does tamoxifen work differently from other hormone medications?

  • Anti-estrogen in the breast: Inhibits the growth of HR+ breast cancer cells.

  • Pro-Estrogen in the uterus and bones: Stimulates estrogen receptors in the uterus (increasing the risk of endometrial cancer) and in bones (helping prevent osteoporosis in postmenopausal women).

  • Suitable for both premenopausal and postmenopausal women — unlike aromatase inhibitors which are only effective during menopause.

Who needs to use Tamoxifen?

Tamoxifen has several primary indications.

  • Adjuvant therapy in breast cancer: HR+ — used after surgery/chemotherapy for 5-10 years.

  • Neoadjuvant Therapy — In some cases where immediate surgery is not possible for the patient.

  • DCIS (Stage 0) that is ER-positive — reduces the risk of invasive cancer and breast cancer in the other breast.

  • Risk Reduction (Chemoprevention) — In women with high risk factors such as BRCA1/2 mutation and a clear family history.

  • Metastatic HR+ Breast Cancer — A treatment option for metastatic breast cancer.

Read more: What is DCIS?

Common side effects

The following side effects are observed in most patients using Tamoxifen, but they are not serious.

3.1 Vasomotor Symptoms — Hot flashes, night sweats

  • Found in 40-80% of Tamoxifen users.

  • Severity: Mild to moderate

  • Improvement is often seen after 3-6 months of medication.

  • This occurs because the drug blocks estrogen at the hypothalamus level.

3.2 Gynecological symptoms

  • Vaginal discharge is common and harmless.

  • Vaginal dryness — Lubricating can be used.

  • Irregular menstruation in premenopausal patients.

  • Sexual desire decreases.

3.3 Emotional and neurological symptoms

  • Mood changes, easily irritated.

  • Depression — reported in approximately 10-20% of users.

  • Headache

  • Insomnia — especially due to night sweats.

3.4 Other symptoms that may occur.

  • Nausea — often occurs during the initial stages of taking the medication.

  • Weight gain (moderate)

  • Hair loss (usually not severe)

  • dry skin

  • Cataract — found with long-term use.

Side effects that require special monitoring.

The following side effects are rare but dangerous. You need to know the warning signs.

4.1 Endometrial Cancer

Tamoxifen increases the risk of endometrial cancer by approximately 2-3 times when used in postmenopausal women — but the absolute risk is still low (~1 in 500 people/year).

Warning signs that require immediate medical attention:

  • Abnormal vaginal bleeding (especially after menopause).

  • Vaginal discharge with blood.

  • chronic lower abdominal pain

  • Abnormal urination or urination.

Annual pelvic examinations and uterine ultrasounds are recommended while using Tamoxifen.

4.2 Thromboembolism — Blood clot

Tamoxifen increases the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) by approximately 2-3 times , especially during the first two years of use.

Increased risk factors:

  • Age > 50 years

  • History of DVT/PE (pre-existing medical condition).

  • Overweight (BMI > 30)

  • Smoking

  • Use hormonal birth control pills.

  • Having to spend long periods in bed or traveling long distances.

  • Factor V Leiden or other forms of thrombophilia.

DVT/PE warning signs:

  • DVT: Swelling in one leg, pain, redness, and warmth.

  • PE: Sudden chest pain, shortness of breath, coughing up blood, rapid heartbeat.

  • Both symptoms require immediate ER attention.

4.3 Stroke (Cerebrovascular disease)

Tamoxifen slightly increases the risk of ischemic stroke — related to its thromboembolic effect — BEFAST (Balance/Eyes/Face/Arms/Speech/Time) warning signs indicate immediate need for ER service.

4.4 Liver Toxicity (Rare)

Although reported infrequently, periodic liver function tests are recommended — if you experience jaundice (yellowing of the skin and eyes) or severe upper right abdominal pain, seek immediate medical attention.

Managing side effects.

How to reduce side effects and improve quality of life while using Tamoxifen.

5.1 Manage Hot Flashes

  • Wear two layers of loose-fitting clothing to adjust to the temperature.

  • Use a fan or turn on the air conditioner in the bedroom.

  • Avoid triggers — spicy food, alcohol, caffeine, stress.

  • Lose weight if your BMI is high.

  • Safe alternative medications: Venlafaxine, Gabapentin, Clonidine (Consult your doctor).

  • Avoid: Fluoxetine and Paroxetine, as they interfere with the function of Tamoxifen.

  • Acupuncture and Cognitive Behavioral Therapy have been shown to help reduce the risk of illness.

5.2 Managing Gynecological Symptoms

  • Use a hormone-free (water-based) lubricant.

  • Use vaginal moisturizer regularly.

  • Do not use vaginal estrogen without consulting a doctor — it may interfere with tamoxifen.

  • Annual pelvic examination and uterine ultrasound.

5.3 Managing Emotions and Insomnia

  • Exercise regularly (30 minutes a day, 5 days a week).

  • Practice mindfulness/meditation.

  • Avoid alcohol and caffeine in the evening.

  • If you have severe depression, consult a psychiatrist.

Drug interactions to be aware of.

Tamoxifen must be converted to endoxifen in the liver by the enzyme CYP2D6 to exert its full effect — drugs that inhibit CYP2D6 will reduce the effectiveness of tamoxifen.

Drugs to avoid or use with caution (Strong CYP2D6 Inhibitors):

  • Fluoxetine (Prozac) — Avoid.

  • Paroxetine (Paxil) — Avoid.

  • Bupropion (Wellbutrin) — Use with caution.

  • Quinidine — Avoid it.

  • Cinacalcet — Avoid

  • Terbinafine — Avoid.

SSRI medications that are safe to use with Tamoxifen:

  • Venlafaxine (Effexor) — Safe and helps reduce hot flashes.

  • Citalopram (Celexa)

  • Escitalopram (Lexapro)

  • Sertraline (Zoloft)

  • Desvenlafaxine (Pristiq)

Other medications to be cautious of:

  • Warfarin — Tamoxifen enhances the effect of Warfarin → INR may be too high. INR needs to be checked more frequently.

  • Aromatase Inhibitors — Do not use together.

  • Hormonal birth control pills — consult your doctor first.

Tamoxifen vs Aromatase Inhibitors

Comparing two main groups of hormone therapy drugs.

  • Tamoxifen: Effective for both premenopausal and postmenopausal use. Protects bone health during menopause. Increases the risk of endometrial cancer and thrombosis.

  • Aromatase inhibitors (Letrozole, Anastrozole, Exemestane): For postmenopausal use only. More effective than tamoxifen in postmenopausal periods. Does not increase the risk of endometrial cancer. Does not increase thrombosis. However, they can cause bone loss and joint pain.

In high-risk premenopausal women, ovarian suppression (GnRH agonist such as goserelin) in combination with AI may be used instead of tamoxifen — SOFT/TEXT trials.

Duration of Tamoxifen use — 5 years or 10 years.

Standard Duration (5 years):

This is the traditional standard — reducing the risk of recurrence by half and reducing mortality by 30%.

Extended Duration (10 years):

The ATLAS Trial (Davies et al., Lancet 2013) and the aTTom Trial (Gray et al., JCO 2013) showed that 10 years of tamoxifen use reduced recurrence and mortality more significantly compared to 5 years.

  • Recurrence at 15 years: 10 years 21.4% vs 5 years 25.1%

  • Breast cancer mortality: Reduced by approximately 25%.

  • Side Effect Trade-off: Slightly increased risk of endometrial cancer and pulmonary embolism.

The decision between 5 vs 10 years depends on recurrence risk, tolerance of side effects, and patient preferences — the medical team will discuss this with each patient individually.

Monitoring while using Tamoxifen.

Recommended monitoring

  • Every 3-6 months: Physical examination and assessment of symptoms and side effects.

  • Every 6-12 months: Mammogram (remaining breast + breast that underwent surgery)

  • Every year: Internal examination and uterine ultrasound.

  • Every 6-12 months: Liver function tests, lipid profile.

  • Every 1-2 years: Get an eye exam (Ophthalmology) — check for cataracts.

  • DEXA scan: Every 2 years in premenopausal patients (at risk of bone loss).

Why is follow-up treatment at Namarak Hospital necessary?

  • Multidisciplinary team — Breast surgeon + Oncologist + Gynecologist

  • 3D Hologic + Genius AI Mammogram — Accurate annual breast monitoring.

  • Patient Journey Coordinator System — Tracks appointments, provides medication reminders, and manages side effects.

  • Individual assessment — adjust dosage, duration, and choose between Tamoxifen vs. AI as appropriate.

  • Managing side effects — Consult a doctor regarding hot flashes, mood, and gynecology.

  • NCCN standard compliance — all necessary inspections completed.

  • The philosophy of "like visiting a friend's house" — High Tech, High Touch

Frequently Asked Questions (FAQ)

Does Tamoxifen cause weight gain?

Tamoxifen may cause slight to moderate weight gain (average 2-3 kg over 5 years) — due to the hormone's effects on metabolism and appetite — which can be managed with regular exercise and diet control. Weight gain is not a reason to stop the medication.

Does Tamoxifen cause hair loss?

Hair loss from tamoxifen occurs in a small percentage (about 6%) and is usually not as severe as chemotherapy — characterized by slight thinning of hair on the scalp — and mostly improves after stopping the medication or after 6-12 months of continuous use.

Can you get pregnant while using Tamoxifen?

Pregnancy is not recommended while using Tamoxifen — as it may affect the fetus. Women of childbearing age using Tamoxifen should use non-hormonal contraception (e.g., copper IUDs, condoms). After stopping the medication, wait 2-3 months before planning to conceive. Consult your doctor for planning.

Does Tamoxifen really cause uterine cancer?

Tamoxifen increases the risk of endometrial cancer by approximately 2-3 times in postmenopausal women — but the absolute risk is still low (~1 in 500 people/year). In premenopausal women, this risk is very small. The benefits of reducing recurrence of breast cancer significantly outweigh this risk. Annual uterine examinations and ultrasounds + monitoring for abnormal bleeding can help detect it in its early stages.

How long can Tamoxifen be used?

The standard duration is 5 years, while an extended duration of 10 years is an option for patients at high risk of recurrence — ATLAS and aTTom trials showed that 10 years was better than 5 years in terms of recurrence and mortality. The decision depends on recurrence risk, tolerance of side effects, and patient preference.

For premenopausal women, should I use Tamoxifen or an Aromatase Inhibitor + Ovarian Suppressant?

Depending on recurrence risk, SOFT/TEXT trials show that in high-risk premenopausal women (young age, node-positive, large tumor), AI + Ovarian Suppression (Exemestane + Goserelin) is better than Tamoxifen alone — but with more side effects. For low to intermediate risk patients, Tamoxifen remains a good option. The medical team will assess each case individually.

What should I do if I forget to take my Tamoxifen?

If you miss a dose and remember within 12 hours, take it immediately. If more than 12 hours have passed, or it's close to your next dose time, skip that dose and take your next dose as usual. Do not take a double dose to make up for a missed dose. Missing a dose sometimes doesn't affect the overall effectiveness of treatment, but you should always try to take it regularly.

Does Tamoxifen cure breast cancer completely?

Tamoxifen is part of HR+ breast cancer treatment — used in combination with surgery, chemotherapy, radiation therapy, and followed by ongoing treatment for 5-10 years to reduce the risk of recurrence — with Tamoxifen reducing recurrence by half and breast cancer mortality by 30% — most patients who complete and adhere to the treatment plan can live long and fulfilling lives.

About Numarak Hospital

Numarak Hospital is a specialized breast and breast cancer hospital located on Phetchaburi Road, Bangkok. Operating under the philosophy of "Like visiting a friend's house" — High Tech, High Touch — it combines international-standard technology with compassionate care.

For inquiries regarding Tamoxifen, its side effects , or a second opinion, please contact:

Note: This information is for general knowledge purposes only and is not personalized medical advice. Tamoxifen use must be under the supervision of a healthcare professional. Do not adjust your dosage or stop taking the medication without consulting a doctor.

References

  • NCCN Clinical Practice Guidelines—Breast Cancer (Version 2.2025)

  • Davies C, et al. ATLAS Trial — 10 years vs 5 years of Tamoxifen. Lancet 2013;381:805-816

  • Gray RG, et al. aTTom Trial — Extended Tamoxifen. JCO 2013

  • Pagani O, et al. SOFT/TEXT Trials — Ovarian Suppression + AI in Premenopausal Women. NEJM 2014;371:107-118

  • Fisher B, et al. NSABP P-1 Trial — Tamoxifen for Risk Reduction. JNCI 1998

Recent Posts

See All
What Is Breast Cancer? Types, Stages, and Warning Signs (Breast Cancer 101)

มะเร็งเต้านม: ความรู้เบื้องต้นและการดูแลสุขภาพเต้านม มะเร็งเต้านมคือการเจริญเติบโตของเซลล์ในเต้านมที่ผิดปกติและก่อให้เกิดเนื้องอกที่เป็นมะเร็ง มะเร็งเต้านมเป็นมะเร็งที่พบได้บ่อยที่สุดในผู้หญิง แต่ข่าว

 
 
 
ESMO Breast 2026: New Directions in Breast Cancer Treatment — Key Points Summary

สรุปประเด็นสำคัญจาก ESMO Breast 2026 — ทิศทางการรักษามะเร็งเต้านมยุคใหม่ที่เน้น precision oncology, ลดเคมีบำบัด, biomarker-guided therapy, ADCs, ctDNA และคุณภาพชีวิตของผู้ป่วย โดย รศ.พญ.เยาวนุช คงด่าน

 
 
 

Comments


image.png
bottom of page